52LBA Final report of NPC-9902 trial on therapeutic gain and late toxicities by concurrent-adjuvant chemotherapy and/or accelerated fractionation for T3-4N0-1M0 nasopharyngeal carcinoma

A.Lee; S.Y.Tung; A.T.C.Chan; R.Chappell; Y.T.Fu; T.X.Lu; E.H.Tan; D.T.T.Chua; B.OSullivan; R.Tung

首页> 外文期刊>European Journal of Cancer Supplements >52LBA Final report of NPC-9902 trial on therapeutic gain and late toxicities by concurrent-adjuvant chemotherapy and/or accelerated fractionation for T3-4N0-1M0 nasopharyngeal carcinoma

【24h】

52LBA Final report of NPC-9902 trial on therapeutic gain and late toxicities by concurrent-adjuvant chemotherapy and/or accelerated fractionation for T3-4N0-1M0 nasopharyngeal carcinoma

机译：52LBA NPC-9902试验的最终报告，该报告通过并发辅助化疗和/或加速分级治疗T3-4N0-1M0鼻咽癌的治疗获益和晚期毒性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第3期|共1页
作者
A.Lee; S.Y.Tung; A.T.C.Chan; R.Chappell; Y.T.Fu; T.X.Lu; E.H.Tan; D.T.T.Chua; B.OSullivan; R.Tung;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 8503 Final report of NPC-9901trial on therapeutic gain and late toxicities attributed to concurrent-adjuvant chemotherapy for T1-4N2-3M0 nasopharyngeal carcinoma [J] . A.W.M.Lee, S.Y.Tung, D.T.T.Chua, European Journal of Cancer Supplements . 2009,第2期

机译：NPC-9901试验关于T1-4N2-3M0鼻咽癌同时辅助化疗的治疗获益和晚期毒性的最终报告
2. 8503 Final report of NPC-9901trial on therapeutic gain and late toxicities attributed to concurrent-adjuvant chemotherapy for T1-4N2-3M0 nasopharyngeal carcinoma [J] . A.W.M.Lee, S.Y.Tung, D.T.T.Chua, European Journal of Cancer Supplements . 2009,第2期

机译：NPC-9901试验关于T1-4N2-3M0鼻咽癌同时辅助化疗的治疗获益和晚期毒性的最终报告
3. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. [J] . Lee AW, Tung SY, Chan AT, International Journal of Radiation Oncology, Biology, Physics . 2006,第1期

机译：一项针对局部晚期鼻咽癌的同时化疗和/或加速分级治疗获得的治疗获益的随机研究（NPC-9902试用）的初步结果。
4. Analysis of the Curative Effect of the Treatment of the Three-dimensional Conformal Radiotherapy Combination with the Induction Chemotherapy in the Middle-late Nasopharyngeal Carcinoma [C] . Min Ma, Hongying Lin, Shengcun Zhang International Forum on Bioinformatics and Medical Engineering . 2015

机译：三维保形放疗与中期鼻咽癌诱导化疗治疗疗效分析
5. Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis [O] . Li-Rong Wu, Xue-Song Jiang, Xue Song, 2017

机译：局部并发鼻咽癌同时诱导与同时化疗的疗效比较：倾向评分匹配分析
6. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma [O] . Kwong Dora L W, Chan Anthony T C, Lee Anne W M, 2015

机译：试验初步结果NpC-0501评估治疗获益，从并发辅助治疗转为诱导 - 同步放化疗，从氟尿嘧啶转变为卡培他滨，以及从局部晚期鼻咽癌患者转为常规加速放疗治疗分娩

52LBA Final report of NPC-9902 trial on therapeutic gain and late toxicities by concurrent-adjuvant chemotherapy and/or accelerated fractionation for T3-4N0-1M0 nasopharyngeal carcinoma

著录项

相似文献

相关主题

期刊订阅